Bedaquiline

Red

Brand Name(s):Sirturo

Indication:Tuberculosis

Rationale:1,2

Considered:Jan-14

Review Date:Feb-25

Comments:
SIRTURO is indicated for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in patients aged over 12 years when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. See sections 4.2, 4.4 and 5.1.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.
EMC SPC March 2014